Advanced GC Multi-omic Characterization in EU and CELAC Populations

CompletedOBSERVATIONAL
Enrollment

800

Participants

Timeline

Start Date

June 12, 2019

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions
Gastric Cancer
Trial Locations (8)

1081

VU Medical Centre, Amsterdam

46010

Hospital Clínico Univeristario de Valencia, Valencia

8331150

Pontificia Universidad Católica de Chile, Santiago

C1426ANZ

Instituto Alexander Fleming, Buenos Aires

01480

Instituto Nacional de Cancerología de México, México

Unknown

GenPat, Asunción

4200 135

Institute of Pathology and Immunology of University of Porto, Porto

08035

Vall d'Hebron Institut d'Oncologia, Barcelona

All Listed Sponsors
collaborator

Instituto Nacional de Cancerologia de Mexico

OTHER

collaborator

Amsterdam UMC, location VUmc

OTHER

collaborator

Pontificia Universidad Catolica de Chile

OTHER

collaborator

Vall d'Hebron Institute of Oncology

OTHER

collaborator

INSTITUTO ALEXANDER FLEMING

UNKNOWN

collaborator

Hospital Central del IPS

OTHER

collaborator

IPATIMUP - Instituto De Patologia E Imunologia Molecular Da Universidade Do Porto

OTHER

lead

Fundación para la Investigación del Hospital Clínico de Valencia

OTHER

NCT04015466 - Advanced GC Multi-omic Characterization in EU and CELAC Populations | Biotech Hunter | Biotech Hunter